BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6

• Press Releases

  Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer

  February 6, 2026

   · 

  4 min read
• Press Releases

  Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

  February 6, 2026

   · 

  5 min read
• Press Releases

  Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease

  February 6, 2026

   · 

  12 min read
• Press Releases

  Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer

  February 6, 2026

   · 

  6 min read
• Press Releases

  Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting

  February 6, 2026

   · 

  3 min read
• Press Releases

  Coloplast A/S - Interim Financial Report, Q1 2025/26

  February 6, 2026

   · 

  6 min read
• Press Releases

  PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101

  February 6, 2026

   · 

  2 min read
• Press Releases

  Invitation to the Presentation of Cantargia’s Annual Results for 2025

  February 6, 2026

   · 

  1 min read
• Press Releases

  HUTCHMED to Announce 2025 Final Results

  February 6, 2026

   · 

  1 min read
• Press Releases

  NK Cell Therapeutics Autologous vs. Allogeneic: Who Will Lead the Race to Commercialization? - Commentary by Unexakorea

  February 6, 2026

   · 

  1 min read